Acrux Ltd has released a press release.
Trading Halt
Filed with ASX ·
On 6ix: 6ix.com/news/trading-halt-1457
6ix hasn’t read this filing yet.
In the deck
Earlier from Acrux
- AGM Presentation
- FY24 R&D Tax Incentive rebate received
- ASX Small and Mid Cap Conference presentation
- FY24 Full Year Results - Investor Presentation
- Appendix 4E and FY24 Full Year Statutory Accounts
Later from Acrux
- FDA Approval - Nitroglycerin Ointment
- Share Placement successfully concluded and SPP launched
- Investor Presentation
- Share Purchase Plan Offer Booklet
- Commercialisation of Nitroglycerin Ointment
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux